439580
BLUEMTEC Co., Ltd. operates a pharmaceutical distribution platform in South Korea and internationally. It is also involved in the healthcare digital marketing, IT development, fulfilment, pharmaceutical distribution data, and medical staff matching, and logistics businesses. The company was founded in 2015 and is headquartered in Yongin, South Korea.
439580 (439580) - Total Liabilities
Latest total liabilities as of March 2025: ₩63.82 Billion KRW
Based on the latest financial reports, 439580 (439580) has total liabilities worth ₩63.82 Billion KRW as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
439580 - Total Liabilities Trend (2022–2024)
This chart illustrates how 439580's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
439580 Competitors by Total Liabilities
The table below lists competitors of 439580 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KEFI Gold and Copper Plc
PINK:KFFLF
|
USA | $3.74 Million |
|
Tian An China Investments Company Limited
PINK:TIACF
|
USA | $25.35 Billion |
|
Tonymoly Co Ltd
KO:214420
|
Korea | ₩104.48 Billion |
|
PANIN INSURANCE
MU:OA9
|
Germany | €174.16 Trillion |
|
WISeKey International Holding Ltd.
LSE:0RF1
|
UK | £28.43 Million |
|
Akastor ASA
PINK:AKKVF
|
USA | $748.00 Million |
|
Inspirato Inc
NASDAQ:ISPO
|
USA | $362.26 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down 439580's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how 439580's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for 439580 (2022–2024)
The table below shows the annual total liabilities of 439580 from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩68.53 Billion | +46.35% |
| 2023-12-31 | ₩46.82 Billion | +19.49% |
| 2022-12-31 | ₩39.18 Billion | -- |